Cancer Research UK Adopts Dharmacon Gene-Silencing Technology
21-Apr-2005 -
Dharmacon, Inc. announced an agreement to provide siRNA libraries to Cancer Research UK. The siRNA libraries, which were developed using Dharmacon's proprietary SMARTselection(TM) and SMARTpool® technology platforms, initially include protein kinase genes and associated pathways. Cancer Research ...
basic research
cell signaling
clinical trials
+5